comparemela.com

W Neal Burnette News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AIM ImmunoTech Inc (AMEX:AIM) Q1 2023 Earnings Call Transcript

AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update

– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones throughout 2023– Lead clinical program, Phase 2 locally advance. | May 15, 2023

AIM ImmunoTech Inc : AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W Neal Burnette, Ph D , as Chairman of its Scientific Advisory Board (SAB)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.